Open access
Open access
Powered by Google Translator Translator

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.

25 Aug, 2021 | 08:59h | UTC

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Related:

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

2 Case Series and Guidance| Lymphadenopathy in COVID-19 Vaccine Recipients

COVID-19 vaccine-linked adenopathies could mimic breast malignancies

 


Stay Updated in Your Specialty

No spam, just news.